Public Safety and Neighborhood Services Committee Regular Meeting – July 11, 2024
STREAMING COPY IN PREPARATION — RECORDING AVAILABLE FROM THE ORIGINAL SOURCE
Public Safety and Neighborhood Services Committee Regular Meeting – July 11, 2024
The San Francisco Board of Supervisors' Public Safety and Neighborhood Services Committee, chaired by Vice Chair Joel Engardio and joined by Supervisor Dorsey (with Chair Stefani excused), met on July 11, 2024, to consider one ordinance regarding buprenorphine availability and three liquor license applications. All items were forwarded to the full Board of Supervisors with positive recommendations.
Discussion Items
Item 1: Health Code Amendment – Requiring Retail Pharmacies to Stock Buprenorphine
- Sponsored by Supervisor Dorsey and co-sponsored by Supervisors Mandelman, Ronan, Preston, and Peskin. Presented by Dr. Jeffrey Hom of the Department of Public Health.
- Key context: In 2023, 810 San Franciscans died from unintentional overdoses, 80% involving fentanyl. Buprenorphine, a gold-standard medication for opioid use disorder, reduces mortality risk by up to 50%.
- A 2023 study found only 47% of California pharmacies stocked buprenorphine; a 2024 DPH survey found just 44% of San Francisco retail pharmacies had it in stock on the day called. The proposed ordinance would require all retail pharmacies that dispense controlled substances to stock sufficient buprenorphine to fill existing prescriptions and at least two new prescriptions (24 mg/day for 7 days). A three-day grace period is allowed for restocking. Noncompliance would result in administrative penalties.
- Discussion included barriers to prescribing, such as stigma among healthcare providers. No public comment was offered.
- Motion to forward to the full board as a committee report with a positive recommendation passed 2–0 (Engardio and Dorsey aye; Stefani excused). The item is scheduled for the July 16 Board of Supervisors meeting.
Item 2: Liquor License Issuance – 475 Haight Street (The Faight)
- Application for a Type 90 on-sale general music venue license by Faight Collective, SFLC. SFPD reported one letter of protest (denied by ABC) and zero letters of support. The location is in a high crime and high concentration area; Northern Station had no opposition.
- Conditions recommended: noise monitoring, active loitering prevention, litter maintenance, and two uniformed security guards during live entertainment.
- No public comment was received. The committee voted 2–0 to forward the resolution with a positive finding of public convenience and necessity to the full board (scheduled for July 23 per standard timeline).
Item 3: Liquor License Transfer – 3250 Mission Street (Evergreen Market)
- Application for a Type 21 off-sale general license by Ayabs Community Market Corp. SFPD reported 55 letters of protest (described by the applicant as form letters from a competitor) and 19 letters of support, including from the Cali 824 Latino Culture District. The area is low crime but high concentration; Ingleside Station had no opposition.
- The applicant stated the business will be a full-service market with imported alcohol, meat counter, and produce, not competing with nearby liquor stores.
- No public comment was offered. The committee voted 2–0 to forward the resolution with a positive recommendation.
Item 4: Liquor License Transfer – 340 Balboa Street (Tomorrow's Wine)
- Application for a Type 20 off-sale beer and wine license (with instructional tasting) by Tofino Wines Inc. SFPD reported zero letters of protest or support. The location is low crime and low concentration; Richmond Station had no opposition.
- The applicant, a longtime natural wine retailer, is relocating from Geary Masonic to Balboa Street. Conditions include litter control, loitering prevention, and signage during tastings.
- No public comment was received. The committee voted 2–0 to forward the resolution with a positive finding.
Key Outcomes
- All four agenda items were approved by the committee (2–0) and forwarded to the full Board of Supervisors with positive recommendations.
- Item 1 will appear on the board’s July 16 agenda; items 2–4 are expected to appear on the July 23 agenda unless otherwise noted.
- No public testimony was given on any item.
Meeting Transcript
I'm Supervisor Joel Engario, Vice Chair of the Committee. And to my left is Supervisor Dorsey. The clerk is Ms. Monique Creighton. Also, I'd like to thank Corwin Cooley for at SFGov TV for staffing this meeting. Madam Clerk, do you have any announcements? Yes, please make sure to silence all cell phones and electronic devices. Documents to be included as part of the file should be submitted to the clerk. Public comment will be taken on each item on this agenda. When your item of interest comes up and public comment is called, please line up to speak on your right. Alternatively, you may submit public comment in writing in either of the following ways. First, you may email them to myself, the Public Safety and Neighborhood Services Committee clerk at M O N I Q U E. C R A Y T O N at S F G-O V dot O R G, or you may send your written comments via U.S. Postal Service to our office in City Hall. Number one, Dr. Carlton Be Goodlit Place, Room 244, San Francisco, California 94102. If you submit public comment in writing, it will be forwarded to the supervisors and also included as part of the official file in which you are commenting. Finally, items acted upon today are expected to appear on the Board of Supervisors' agenda of July 23rd, 2024 unless otherwise stated. Before we begin today's meeting, I'd like to make a motion to excuse Supervisor Catherine Stephanie. And on the motion to excuse uh Supervisor Catherine Stephanie, Vice Chair and Guardio. Aye. Vice Chair and Guardio, I. Member Dorsey. Member Dorsey, I have two eyes with Chair Stephanie Excused. Madam Clerk, will you please call the first item? Yes, the first item is an ordinance amending the health code to require each retail pharmacy in San Francisco that stocks control substance prescription drugs to stock sufficient bupore for norphin to provide for at least two new prescriptions, provide for an affirmative defense for retail pharmacy pharmacies that order replacement prescriptions and establish penalties for violating this requirement to stock sufficient bupore buporphin. I would like to note that this item will be presented as a committee report at the July 16th Board of Supervisors meeting. Thank you, Madam Clerk. This item is sponsored by Supervisor Dorsey's office. I will turn it over to Dr. Jeffrey Haum from the Department of Public Health to present. Oh, uh Cheryl. Sure. Thank you. Uh Chair Engardio, I just wanted to say a few words to um introduce this. Um the legislation before this committee today would require all retail pharmacies in San Francisco to stock buprenorphine, a gold standard medication for opioid use disorder that is known to relieve withdrawal symptoms, reduce cravings, facilitate long-term recovery, and cut mortality risk by as much as 50%. If San Francisco is to succeed in supporting and incentivizing long-term recovery from addiction, ensuring the availability of buprenorphine at our local pharmacies must be part of it. And few surpstances ever to emerge in our illicit drug supply have ever been more potently addictive or more deadly than the synthetic opioid fentanyl. Today, anyone making the brave and difficult choice to seek recovery from an opioid use disorder, and especially one involving fentanyl, is racing the clock. They face overpowering cravings and debilitating withdrawal symptoms. And if life-saving medications like bufenorphine aren't readily available to offer relief, we know that life-threatening street drugs abound as alternatives. That's why it is a moral imperative to expand access to medically assisted treatment in the midst of the drug overdose crisis we face. I just want to say how incredibly grateful I am to the Department of Public Health for identifying local problems with buprenorphine uh availability and for recommending this worthwhile approach to address it. Thanks in particular to Dr. Jeff Raham for his leadership and his partnership on this. I will give a shout out as well to Dr. Colfax and Dr. Cunnins for their work and just being such a partner to me. Um, as you as you know, this is this is something that for me is personal. It is why I asked for a job that I never thought I would want, let alone have.
openpublica.com